# EDGAR Filing Document

**Accession Number:** 0001820721
**File Stem:** 0001820721-23-000057
**Filing Date:** 2023-3
**Character Count:** 68876
**Document Hash:** 2d8dccbf134e14ead1655986d7a9d951
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001820721-23-000057.hdr.sgml**: 20230321

**ACCESSION NUMBER**: 0001820721-23-000057

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 28

**CONFORMED PERIOD OF REPORT**: 20230321

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230321

**DATE AS OF CHANGE**: 20230321

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Array Technologies, Inc.
- **CENTRAL INDEX KEY:** 0001820721
- **STANDARD INDUSTRIAL CLASSIFICATION:** MISCELLANEOUS MANUFACTURING INDUSTRIES [3990]
- **IRS NUMBER:** 832747826
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39613
- **FILM NUMBER:** 23749845

**BUSINESS ADDRESS:**
- **STREET 1:** 3901 MIDWAY PLACE NE
- **CITY:** ALBUQUERQUE
- **STATE:** NM
- **ZIP:** 87109
- **BUSINESS PHONE:** (505) 881-7567

**MAIL ADDRESS:**
- **STREET 1:** 3901 MIDWAY PLACE NE
- **CITY:** ALBUQUERQUE
- **STATE:** NM
- **ZIP:** 87109

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ATI Intermediate Holdings, LLC
- **DATE OF NAME CHANGE:** 20200810

?xml version="1.0" ? arry-20230321

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549** 

**FORM 8-K** 

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d)**

**of the Securities Exchange Act of 1934**

**Date of Earliest Event Reported: March 21, 2023** 

**ARRAY TECHNOLOGIES, INC.**

**(Exact Name of Registrant as Specified in its Charter)** 

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-39613** | **83-2747826** |
| **(State or Other Jurisdiction**<br>**of Incorporation)** | **(Commission**<br>**File Number)** | **(IRS Employer**<br>**Identification No.)** |

---

**3901 Midway Place NE**

**Albuquerque, New Mexico 87109**

**(Address of Principal Executive Offices) (Zip Code)**

**Registrant's telephone number, including area code: (505) 881-7567** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br>**Symbol(s)** | **Name of each exchange**<br>**on which registered** |
| **Common Stock, $0.001 Par Value** | **ARRY** | **Nasdaq Global Market** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 2.02 Results of Operations and Financial Condition.**

On March 21, 2023, the Company announced its financial results as of and for the quarter and year ended December 31, 2022, by issuing a press release, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K and incorporated by reference herein. In the press release, the Company also announced that it would be holding a conference call on March 21, 2023, at 5:00 p.m. Eastern Time to discuss its financial results and provide an investor presentation. A copy of the investor presentation will be posted to our website at www.arraytechinc.com and is attached as Exhibit 99.2 hereto.

The information included in Item 2.02 of this Current Report on Form 8-K and the exhibits attached hereto are being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, regardless of any general incorporation language in any such filing.

Certain non-GAAP measures are set forth in Exhibit 99.1 and Exhibit 99.2. A non-GAAP financial measure is a numerical measure of a company's performance that either excludes or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented in accordance with GAAP. However, non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. The disclosure in Exhibit 99.1 and Exhibit 99.2 allows investors to reconcile the non-GAAP measures to GAAP.

**Item 9.01 Financial Statements and Exhibits.**

(d) *Exhibits*.

The following exhibits are filed as part of this report:

---

| | |
|:---|:---|
| **Exhibit#** | **Description** |
| 99.1 | <u>[Press Release of Array Technologies, Inc., dated March 21, 2023.](exhibit9912022yepressrelea.htm)</u> |
| 99.2 | <u>[Investor Presentation of Array Technologies, Inc., dated March 21, 2023.](a2022_q4earningspresenta.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

**SIGNATURE** 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **Array Technologies, Inc.** | **Array Technologies, Inc.** |
| Date: March 15, 2023 | By: | /s/ Tyson Hottinger |
|  |  | Name: Tyson Hottinger |
|  |  | Title: Chief Legal Officer |

---

## Exhibit 99.1

March 21, 2023

**Array Technologies, Inc. Reports Financial Results for the Fourth Quarter and Full Year 2022 – Delivers full year revenue increase of 92% from 2021 to $1.6 billion, exiting the year with Fourth Quarter 2022 gross margin of 20.0%** 

**Fourth Quarter 2022 Financial Highlights** 

&nbsp;&nbsp;&nbsp;&nbsp;• Revenue of $402.1 million

&nbsp;&nbsp;&nbsp;&nbsp;• Net loss to common stockholders of $17.3 million

&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA<sup>(1)</sup> of $51.7 million

&nbsp;&nbsp;&nbsp;&nbsp;• Basic and diluted net loss per share of $0.11

&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted diluted net income per share<sup>(1)</sup> of $0.10

&nbsp;&nbsp;&nbsp;&nbsp;• Executed contracts and awarded orders at December 31, 2022 totaling $1.9 billion

**Full Year 2022 Financial Highlights** 

&nbsp;&nbsp;&nbsp;&nbsp;• Revenue of $1,638 million

&nbsp;&nbsp;&nbsp;&nbsp;• Net loss to common stockholders of $43.6 million

&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA<sup>(1)</sup> of $128.7 million

&nbsp;&nbsp;&nbsp;&nbsp;• Basic and diluted net loss per share of $0.29

&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted diluted net income per share<sup>(1)</sup> of $0.38

<sup>(1)</sup> A reconciliation of the GAAP to the most comparable Non-GAAP results is included below.

ALBUQUERQUE, NM — (GLOBE NEWSWIRE) — Array Technologies (NASDAQ: ARRY) ("Array" or "the Company"), a leading provider of tracker solutions, software and services for utility-scale solar energy projects, today announced financial results for its fourth quarter and full year ended December 31, 2022.

"I am pleased to announce that our 2022 results finished at the high-end of our preliminary ranges. Accordingly, revenue, adjusted EBITDA, and adjusted EPS all exceeded the midpoint of our full year guidance range as we had a very strong close out to our year," said Kevin Hostetler, Chief Executive Officer. "As we enter 2023, we do so with an incredible amount of momentum: our $1.9 billion orderbook is priced to support long-term sustainability of our high teens to low twenties margin range. The significant amount of cashflow produced in the second half of 2022 solidifies our liquidity position and dramatically improves our leverage position. And, finally, with the launch of OmniTrack and the availability of the STI H250 in the U.S., coupled with an expanded SmarTrack software powering all of our product lines, we have what we believe to be the strongest tracker hardware and software product portfolio in the industry. Against that backdrop, our team remains focused on execution in our domestic and international markets, and we look towards further operational and financial improvements, which you can see embedded in our expectations for 2023. As a reminder, our guidance does not assume any potential benefits from the IRA related to the domestic content provision and the tracker manufacturing credits, meaning we view both as being additive to results in 2023 if resolution is reached on either topic. Regardless of the timing of those benefits, Array is well positioned as a key player in the global utility-scale solar supply chain, and we are working closely with our customers every day to provide them with premium products and services to fulfill their specified project needs," concluded Mr. Hostetler.

------

**Fourth Quarter 2022 Financial Results**

Revenues increased 83% to $402.1 million, compared to $219.9 million for the prior-year period, primarily driven by a higher Average Selling Price for our Array Duratrack product and the acquisition of STI, which contributed $132.5 million in the quarter.

Gross profit increased 683% to $80.5 million compared to $10.3 million in the prior year period, driven by the increase in volume both from the acquisition of STI as well as our organic growth. Gross margin increased to 20.0% from 4.7% driven by a larger portion of higher priced contracts and the addition of STI.

Operating expenses increased to $64.2 million compared to $30.3 million during the same period in the prior year. The higher expense is primarily related to a $24.7 million increase in amortization expense related to the STI acquisition. The remaining increase represents the additional operating expenses from the STI business as well as higher headcount related costs to support the Company's growth and innovation.

Net loss to common stockholders was $17.3 million compared to a net loss to common stockholders of $32.1 million during the same period in the prior year, and basic and diluted loss per share were $0.11 compared to basic and diluted loss per share of $0.24 during the same period in the prior year.

Adjusted EBITDA increased to $51.7 million, compared to $0.5 million for the prior-year period.

Adjusted net income was $15.0 million compared to adjusted net loss of $7.8 million during the same period in the prior year and adjusted basic and adjusted diluted net income per share was $0.10 compared to adjusted diluted net loss per share of $0.06 during the same period in the prior year.

**Full Year 2022 Financial Results**

Revenues increased 92% to $1,637.5 million, compared to $853.3 million for the prior-year period, driven by an organic increase of $414.6 million, or 49%, driven by both an increase in the total number of MWs shipped and an increase in ASP. Revenue growth was also driven by the acquisition of STI Norland which contributed revenue of $369.7 million.

Gross profit increased 174% to $227.3 million, compared to $82.9 million in the prior year period, driven by the increase in volume both from the acquisition of STI as well as our organic growth. Gross margin increased to 13.9% from 9.7% driven by a larger portion of higher priced contracts and the addition of STI.

Operating expenses increased 128% to $245.4 million compared to $107.6 million during the same period in the prior year. The higher expense is primarily related to a $74.7 million increase in amortization expense related to the STI acquisition. The remaining increase represents the additional operating expenses from the STI business as well as higher headcount related costs to support the Company's growth and innovation.

Net loss to common stockholders was $43.6 million compared to a net loss of $66.1 million during the same period in the prior year, and basic and diluted loss per share were $0.29 compared to basic and diluted loss per share of $0.51 during the same period in the prior year.

Adjusted EBITDA increased to $128.7 million, compared to $43.2 million for the prior-year period.

------

Adjusted net income was $57.3 million compared to adjusted net income of $8.7 million during the same period in the prior year and adjusted basic and diluted net income per share was $0.38 compared to adjusted diluted net income per share of $0.07 during the same period in the prior year.

**Executed Contracts and Awarded Orders**

Total executed contracts and awarded orders at December 31, 2022 were $1.9 billion, with $1.4 billion from our Array Legacy Operations segment and $0.5 billion from STI Norland.

**Full Year 2023 Guidance**

For the year ending December 31, 2023, the Company expects:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue to be in the range of $1,800 million to $1,950 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA<sup>(4)</sup> to be in the range of $240 million to $265 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted net income per share<sup>(4)</sup> to be in the range of $0.75 to $0.85

(4) A reconciliation of projected adjusted EBITDA and adjusted net income per share, which are forward-looking measures that are not prepared in accordance with GAAP, to the most directly comparable GAAP financial measures, is not provided because we are unable to provide such reconciliation without unreasonable effort. The inability to provide a quantitative reconciliation is due to the uncertainty and inherent difficulty predicting the occurrence, the financial impact and the periods in which the components of the applicable GAAP measures and non-GAAP adjustments may be recognized. The GAAP measures may include the impact of such items as non-cash share-based compensation, revaluation of the fair-value of our contingent consideration, and the tax effect of such items, in addition to other items we have historically excluded from adjusted EBITDA and adjusted net income per share. We expect to continue to exclude these items in future disclosures of these non-GAAP measures and may also exclude other similar items that may arise in the future (collectively, "non-GAAP adjustments"). The decisions and events that typically lead to the recognition of non-GAAP adjustments are inherently unpredictable as to if or when they may occur. As such, for our 2023 guidance, we have not included estimates for these items and are unable to address the probable significance of the unavailable information, which could be material to future results.

**Conference Call Information**

Array management will host a conference call to discuss their fourth quarter and full year 2022 financial results on March 21, 2023, at 5:00 p.m. Eastern Time. The conference call can be accessed live over the phone by dialing (877)-451-6152 (domestic) or 1-201-389-0879 (international). A telephonic replay will be available approximately three hours after the call by dialing (844)-512-2921, or for international callers, (412)-317-6671. The passcode for the live call and the replay is 13735768. The replay will be available until 11:59 p.m. (ET) on April 4, 2023.

Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of the Company's website at <u>http://ir.arraytechinc.com</u>. The online replay will be available for 30 days on the same website immediately following the call.

**About Array Technologies, Inc.**

Array Technologies (NASDAQ: ARRY) is a leading American company and global provider of utility-scale solar tracker technology. Engineered to withstand the harshest conditions on the planet, Array's high-quality solar trackers and sophisticated software maximize energy production, accelerating the adoption of cost-effective and sustainable energy. Founded and headquartered in the United States, Array relies on its diversified global supply chain and customer-centric approach to deliver, commission and support solar energy developments around the world, lighting the way to a brighter, smarter future for clean energy. For more news and information on Array, please visit arraytechinc.com.

------

**Investor Relations Contact: &nbsp;&nbsp;&nbsp;&nbsp;**

Array Technologies, Inc.

Investor Relations

505-437-0010

<u>investors@arraytechinc.com</u>

**Forward-Looking Statements** 

This press release contains forward-looking statements that are based on our management's beliefs and assumptions and on information currently available to our management. Forward-looking statements include information concerning our projected future results of operations, business strategies, our continued integration of STI Norland and industry and regulatory environment. Forward-looking statements include statements that are not historical facts and can be identified by terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "seek," "should," "will," "would" or similar expressions and the negatives of those terms.

Array's actual results and the timing of events could materially differ from those anticipated in such forward-looking statements as a result of certain risks, uncertainties and other factors, including without limitation: we may be unable to successfully integrate the business of STI Norland into our business or achieve the anticipated benefits of the acquisition of STI Norland; on March 25, 2022, the Department of Commerce initiated a circumvention inquiry on the anti-dumping duty and countervailing duty orders related to crystalline silicone photovoltaic cells, which inquiry presents risks and uncertainty that are difficult to predict and accordingly the ranges provided assume no material negative impact resulting from such inquiry; if demand for solar energy projects does not continue to grow or grows at a slower rate than we anticipate, our business will suffer; a loss of one or more of our significant customers, their inability to perform under their contracts, or their default in payment, could harm our business and negatively impact revenue, results of operations and cash flows; the impact of the ongoing conflict in Ukraine on our business; uncertain credit and global financial markets, including rising inflation and interest rates and recent bank failures; the ongoing COVID-19 pandemic has materially and adversely affected our business and results of operations, and the duration and extent to which it will continue to adversely impact our business and results of operations remains uncertain and could be material; significant changes in the costs of raw materials could adversely affect our financial performance; defects or performance problems in our products could result in loss of customers, reputational damage and decreased revenue, and we may face warranty, indemnity and product liability claims arising from defective products; existing electric utility industry policies and regulations, and any subsequent changes, may present technical, regulatory and economic barriers to the purchase and use of solar energy systems, which may significantly reduce demand for our products or harm our ability to compete; changes in the U.S. trade environment, including the imposition of import tariffs, could adversely affect the amount or timing of our revenues, results of operations or cash flows; and the other risks and uncertainties described in more detail in the Company's most recent Annual Report on Form 10-K and other documents on file with the SEC, each of which can be found on our website www.arraytechinc.com.

Except as required by law, we assume no obligation to update these forward-looking statements, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

**Non-GAAP Financial Information**

This presentation includes certain financial measures that are not presented in accordance with U.S. generally accepted accounting principles ("GAAP"), including Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income per share. We define Adjusted EBITDA as net income (loss) to common shareholders plus (i) interest expense, (ii) other (income) expense, (iii) income tax expense (benefit), (iv) depreciation expense, (v) amortization of intangibles, (vi) equity-based compensation, (vii) remeasurement of the fair value of contingent consideration, (viii) ERP implementation costs, (ix) certain legal expense and settlements, and (x) other costs. We define Adjusted Net Income as net income (loss) to common shareholders plus (i) amortization of intangibles, (ii) amortization of debt discount and issuance costs (iii) equity-based compensation, (iv) remeasurement of the fair value of contingent consideration, (v) ERP implementation costs, (vi) certain legal expense and settlements, (vii) other costs, and (viii) income tax (expense) benefit of adjustments. A detailed

------

reconciliation between GAAP results and results excluding special items ("non-GAAP") is included within this presentation. We define Adjusted Net Income per share as Adjusted Net Income divided by the diluted weighted average number of shares outstanding for the applicable period.

We believe that these non-GAAP financial measures are provided to enhance the reader's understanding of our past financial performance and our prospects for the future. Our management team uses these non-GAAP financial measures in assessing the Company's performance, as well as in planning and forecasting future periods. The non-GAAP financial information is presented for supplemental informational purposes only and should not be considered a substitute for financial information presented in accordance with GAAP, and may be different from similarly titled non-GAAP measures used by other companies.

Among other limitations, Adjusted EBITDA and Adjusted Net Income do not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments; do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations; do not reflect income tax expense or benefit; and other companies in our industry may calculate Adjusted EBITDA and Adjusted Net Income differently than we do, which limits their usefulness as comparative measures. Because of these limitations, Adjusted EBITDA and Adjusted Net Income should not be considered in isolation or as substitutes for performance measures calculated in accordance with GAAP. We compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA and Adjusted Net Income on a supplemental basis. You should review the reconciliation of net income (loss) to Adjusted EBITDA and Adjusted Net Income below and not rely on any single financial measure to evaluate our business.

------

**Array Technologies, Inc. and Subsidiaries** 

**Consolidated Balance Sheets *(unaudited)***

*(in thousands, except per share and share amounts)*

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| ASSETS | ASSETS | ASSETS |
| Current assets |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | $133901 | $367670 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable, net | 421183 | 236009 |
| &nbsp;&nbsp;&nbsp;&nbsp;Inventories, net | 233159 | 205653 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax receivables | 3532 | 9052 |
| &nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other | 39434 | 33649 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | 831209 | 852033 |
| Property, plant and equipment, net | 23174 | 10692 |
| Goodwill | 416184 | 69727 |
| Other intangible assets, net | 386364 | 174753 |
| Deferred tax assets | 16466 | 9345 |
| Other assets | 32655 | 26429 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $1706052 | $1142979 |
| LIABILITIES, REDEEMABLE PERPETUAL PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) | LIABILITIES, REDEEMABLE PERPETUAL PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) | LIABILITIES, REDEEMABLE PERPETUAL PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) |
| Current liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | $170430 | $92002 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other | 54895 | 38494 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accrued warranty reserve | 3690 | 3192 |
| &nbsp;&nbsp;&nbsp;&nbsp;Income tax payable | 6881 | 60 |
| &nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 178922 | 99575 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of contingent consideration | 1200 | 1773 |
| &nbsp;&nbsp;&nbsp;&nbsp;Current portion of debt | 38691 | 4300 |
| &nbsp;&nbsp;&nbsp;&nbsp;Other current liabilities | 10553 | 5909 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | 465262 | 245305 |
| Deferred tax liability | 72606 |  |
| Contingent consideration, net of current portion | 7387 | 12804 |
| Other long-term liabilities | 14808 | 5557 |
| Long-term warranty | 1786 |  |
| Long-term debt, net of current portion | 720352 | 711056 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 1282201 | 974722 |
| Commitments and contingencies |  |  |

---

------

**Array Technologies, Inc. and Subsidiaries** 

**Consolidated Balance Sheets *(unaudited)*** *(continued)*

*(in thousands, except per share and share amounts)*

---

| | | |
|:---|:---|:---|
| | **December 31,** | **December 31,** |
| | **2022** | **2021** |
| &nbsp;&nbsp;&nbsp;&nbsp;Series A Redeemable Perpetual Preferred Stock: $0.001 par value; 500,000 shares authorized; 406,000 and 350,000 issued, respectively; liquidation preference of $400.0 million and $350.0 million, respectively | 299570 | 237462 |
| Stockholders' equity (deficit) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Preferred stock $0.001 par value; 4,500,000 shares authorized; none issued |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock $0.001 par value; 1,000,000,000 shares authorized; 150,513,104 and 135,026,940 issued, respectively | 150 | 135 |
| &nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital | 383176 | 202562 |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated deficit | (267470) | (271902) |
| &nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive income | 8425 |  |
| Total stockholders' equity (deficit) | 124281 | (69205) |
| Total liabilities, redeemable perpetual preferred stock and stockholders' equity (deficit) | $1706052 | $1142979 |

---

------

**Array Technologies, Inc. and Subsidiaries** 

**Consolidated Statements of Operations *(unaudited)***

*(in thousands, except per share amounts)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>December 31,** | **Three Months Ended<br>December 31,** | **Year Ended<br>December 31,** | **Year Ended<br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Revenue | $402071 | $219876 | $1637546 | $853318 |
| Cost of revenue | 321551 | 209587 | 1410270 | 770459 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 80520 | 10289 | 227276 | 82859 |
| **Operating expenses** |  |  |  |  |
| General and administrative | 37713 | 22695 | 150777 | 80974 |
| Contingent consideration | 1474 | 1625 | (4507) | 2696 |
| Depreciation and amortization | 24984 | 5981 | 99139 | 23930 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 64171 | 30301 | 245409 | 107600 |
| Income (loss) from operations | 16349 | (20012) | (18133) | (24741) |
| **Other income (expense)** |  |  |  |  |
| Other income (expense), net | 2816 | (408) | 2789 | (905) |
| Legal settlement |  |  | 42750 |  |
| Foreign currency gain (loss) | (813) |  | 1155 |  |
| Interest expense | (9804) | (6706) | (33513) | (35475) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other income (expense) | (7801) | (7114) | 13181 | (36380) |
| Income (loss) before income tax benefit | 8548 | (27126) | (4952) | (61121) |
| Income tax (benefit) expense | 13799 | (5225) | (9384) | (10718) |
| **Net income (loss)** | (5251) | (21901) | 4432 | (50403) |
| Preferred dividends and accretion | 12009 | 10236 | 48054 | 15715 |
| **Net income (loss) to common shareholders** | $(17260) | $(32137) | $(43622) | $(66118) |
| Loss per common share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.11) | $(0.24) | $(0.29) | $(0.51) |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.11) | $(0.24) | $(0.29) | $(0.51) |
| Weighted average common shares outstanding |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Basic | 150463 | 134991 | 149819 | 129984 |
| &nbsp;&nbsp;&nbsp;&nbsp;Diluted | 150463 | 134991 | 149819 | 129984 |

---

------

**Array Technologies, Inc. and Subsidiaries** 

**Consolidated Statements of Cash Flows *(unaudited)***

*(in thousands)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year Ended <br>December 31,** | **Year Ended <br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| **Operating activities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | $(5251) | $(21901) | $4432 | $(50403) |
| &nbsp;&nbsp;&nbsp;&nbsp;Adjustments to net income (loss): |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for (recovery of) bad debts | 1939 | 107 | 2599 | (467) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred tax (benefit) expense | (3362) | (3066) | (31565) | (10102) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 26102 | 6492 | 101059 | 25946 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amortization of debt discount and issuance costs | 1854 | 1383 | 6857 | 15036 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Equity-based compensation | 3305 | 2051 | 14982 | 13757 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Contingent consideration | 1474 | 1625 | (4507) | 2696 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Warranty provision | 2098 | 211 | 6439 | 516 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for inventory obsolescence | 1474 | 336 | (859) | 990 |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in operating assets and liabilities, net of acquisition |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts receivable | 62052 | (66008) | (76984) | (116848) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Inventories | 35143 | (32863) | 20870 | (88184) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax receivables | 9221 | (1570) | 5611 | 8106 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Prepaid expenses and other | 2795 | (15456) | 19124 | (21226) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable | (29406) | 6689 | 12667 | 7015 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accrued expenses and other | (42534) | 7450 | (1263) | 9133 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Warranty payments | 373 |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax payable | (3706) | (569) | (755) | (8754) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Lease liabilities | 1870 | (116) | 3784 | 221 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Deferred revenue | 24230 | 17855 | 59002 | (50619) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) operating activities | 89671 | (97350) | 141493 | (263187) |
| **Investing activities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Purchase of property, plant and equipment | (3931) | (1105) | (10619) | (3357) |
| &nbsp;&nbsp;&nbsp;&nbsp;Acquisition of STI, net of cash acquired |  |  | (373818) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Investment in equity security |  |  |  | (11975) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (3931) | (1105) | (384437) | (15332) |
| **Financing activities:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from Series A issuance |  |  | 33098 | 224987 |

---

------

**Array Technologies, Inc. and Subsidiaries** 

**Consolidated Statements of Cash Flows *(unaudited)*** *(continued)*

*(in thousands)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year Ended <br>December 31,** | **Year Ended <br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from common stock issuance |  |  | 15885 | 120645 |
| &nbsp;&nbsp;&nbsp;&nbsp;Series A equity issuance costs | (726) |  | (1893) | (7195) |
| &nbsp;&nbsp;&nbsp;&nbsp;Common stock issuance costs |  |  | (450) | (3873) |
| &nbsp;&nbsp;&nbsp;&nbsp;Dividends paid on Series A Preferred |  | (8051) | (18670) | (8051) |
| &nbsp;&nbsp;&nbsp;&nbsp;Payments on revolving credit facility |  | (24033) | (116000) | (126033) |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from revolving credit facility |  | 24033 | 116000 | 126033 |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of other debt | 10280 |  | 20188 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Proceeds from issuance of convertible notes |  | 413321 |  | 413321 |
| &nbsp;&nbsp;&nbsp;&nbsp;Premium paid on capped call |  | (52870) |  | (52870) |
| &nbsp;&nbsp;&nbsp;&nbsp;Fees paid on issuance of convertible notes |  | (1591) |  | (1591) |
| &nbsp;&nbsp;&nbsp;&nbsp;Principal payments on term loan facility | (11075) | (1075) | (14300) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Principal payments on other debt | (23185) |  | (23935) | (133225) |
| &nbsp;&nbsp;&nbsp;&nbsp;Contingent consideration |  |  | (1483) | (7810) |
| &nbsp;&nbsp;&nbsp;&nbsp;Debt issuance costs |  |  |  | (6590) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by (used in) financing activities | (24706) | 349734 | 8440 | 537748 |
| Effect of exchange rate changes on cash and cash equivalent balances | 10089 |  | 735 |  |
| Net change in cash and cash equivalents | 71123 | 251279 | (233769) | 259229 |
| Cash and cash equivalents, beginning of period | 62778 | 116391 | 367670 | 108441 |
| Cash and cash equivalents, end of period | $133901 | $367670 | $133901 | $367670 |

---

------

**Array Technologies, Inc.**

**Adjusted EBITDA and Adjusted Net Income Reconciliation *(unaudited)***

*(in thousands, except per share amounts)*

The following table reconciles Net Income (loss) to Adjusted EBITDA:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year Ended <br>December 31,** | **Year Ended <br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Net income (loss) | $(5251) | $(21901) | $4432 | $(50403) |
| Preferred dividends and accretion | 12009 | 10236 | 48054 | 15715 |
| Net loss to common shareholders | $(17260) | $(32137) | $(43622) | $(66118) |
| Other income (expense), net | (2816) | 408 | (2789) | 905 |
| Legal settlement<sup>(a)</sup> |  |  | (42750) |  |
| Foreign currency (gain) loss | 813 |  | (1155) |  |
| Preferred dividends and accretion | 12009 | 10236 | 48054 | 15715 |
| Interest expense | 9804 | 6706 | 33513 | 35475 |
| Income tax (benefit) expense | 13799 | (5225) | (9384) | (10718) |
| Depreciation expense | 704 | 614 | 2571 | 2439 |
| Amortization of intangibles | 24667 | 5877 | 98188 | 23507 |
| Equity-based compensation | 3091 | 2052 | 14768 | 16323 |
| Contingent consideration | 1474 | 1625 | (4507) | 2696 |
| Legal expense<sup>(b)</sup> | 984 | 1549 | 5990 | 2574 |
| M&A<sup>(c)</sup> | (206) | 3125 | 10564 | 4867 |
| Other costs <sup>(d)</sup> | 4635 | 5623 | 19291 | 15553 |
| **Adjusted EBITDA** | $**51698** | $**453** | $**128732** | $**43218** |

---

.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Settlement in our favor resulting from the action against a competitor in connection with violation of a non-competition agreement and misappropriation of trade secrets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(b)</sup> Represents certain legal fees and other related costs associated with (i) action against a competitor in connection with violation of a non-competition agreement and misappropriation of trade secrets for which a judgement has been entered in our favor, (ii) actions filed against the company and certain officers and directors alleging violations of the Securities Exchange Acts of 1934 and 1933, and (iii) other litigation/settlements. We consider these costs not representative of legal costs that we will incur from time to time in the ordinary course of our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(c)</sup> Represents fees related to the acquisition of STI Norland.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(d)</sup> For the three months ended December 31, 2022, other costs represent (i) $1.4 million related to certain professional fees incurred related to the integration of STI Norland, (ii) $1.8 million in remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event, (iii) $1.4 million of executive transition and payroll related costs that we do not anticipate repeating in the future. For the three months ended December 31, 2021, other costs represent (i) $5.1 million of remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event (ii) $0.5 million of certain professional fees & payroll related costs we do not expect to incur in the future. For the twelve months ended December 31, 2022, (i) $7.2 million related to certain professional fees incurred related to integration, (ii) $6.8 million in remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event, (iii) $5.3 million associated with the transition of CEOs as well as other one-time executive payroll related costs that we do not anticipate repeating in the future. For the twelve months ended December 31, 2021, other costs represent (i) $5.6 million of one-time logistics charges incurred primarily due to supplier constraints and port issues (ii) $6.2 million

------

**Array Technologies, Inc.**

**Adjusted EBITDA and Adjusted Net Income Reconciliation *(unaudited)***

*(in thousands, except per share amounts)*

of remediation and damages incurred because of a shutdown of a key supplier due to a severe weather (iii) $2.0 million of costs associated with our IPO and Follow-on Offering (iv) $1.7 million of professional fees and payroll related costs we do not expect to incur in the future.

The following table reconciles Net Income (loss) to Adjusted Net Income (Loss):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31,** | **Three Months Ended December 31,** | **Year Ended <br>December 31,** | **Year Ended <br>December 31,** |
| | **2022** | **2021** | **2022** | **2021** |
| Net income (loss) | $(5251) | $(21901) | $4432 | $(50403) |
| Preferred dividends and accretion | 12009 | 10236 | 48054 | 15715 |
| Net loss to common shareholders | $(17260) | $(32137) | $(43622) | $(66118) |
| Amortization of intangibles | 24667 | 5877 | 98188 | 23507 |
| Amortization of debt discount and issuance costs | 1854 | 1039 | 6858 | 15036 |
| Preferred accretion | 6009 | 4805 | 23249 | 7489 |
| Equity based compensation | 3091 | 2052 | 14768 | 16323 |
| Contingent consideration | 1474 | 1625 | (4507) | 2696 |
| Legal expense<sup>(a)</sup> | 984 | 1549 | 5990 | 2574 |
| M&A <sup>(b)</sup> | (206) | 4740 | 10564 | 6482 |
| Legal settlement<sup>(c)</sup> |  |  | (42750) |  |
| Other costs<sup>(d)</sup> | 4635 | 5623 | 19291 | 15553 |
| Income tax expense of adjustments<sup>(e)</sup> | (10205) | (3669) | (30773) | (15473) |
| Non-recurring income tax adjustments related to the IRS settlement and CARES Act |  | 662 |  | 662 |
| **Adjusted Net Income (Loss)** | $**15043** | $**(7834)** | $**57256** | $**8731** |
| Loss per common share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $(0.11) | $(0.25) | $(0.29) | $(0.51) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $(0.11) | $(0.25) | $(0.29) | $(0.51) |
| Weighted average common shares outstanding |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 150463 | 130146 | 149819 | 129984 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 150463 | 130146 | 149819 | 129984 |
| Adjusted income (loss) per common share |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $0.10 | $(0.06) | $0.38 | $0.07 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $0.10 | $(0.06) | $0.38 | $0.07 |
| Weighted average common shares outstanding |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 150463 | 134991 | 149819 | 129984 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 151571 | 134991 | 150436 | 130146 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(a)</sup> Represents certain legal fees and other related costs associated with (i) action against a competitor in connection with violation of a non-competition agreement and misappropriation of trade secrets for which a

------

**Array Technologies, Inc.**

**Adjusted EBITDA and Adjusted Net Income Reconciliation *(unaudited)***

*(in thousands, except per share amounts)*

judgement has been entered in our favor, (ii) actions filed against the company and certain officers and directors alleging violations of the Securities Exchange Acts of 1934 and 1933, and (iii) other litigation/settlements. We consider these costs not representative of legal costs that we will incur from time to time in the ordinary course of our business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(b)</sup> Represents fees related to the acquisition of STI Norland.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(c)</sup> Settlement in our favor resulting from the action against a competitor in connection with violation of a non-competition agreement and misappropriation of trade secrets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(d)</sup> For the three months ended December 31, 2022, other costs represent (i) $1.4 million related to certain professional fees incurred related to the integration of STI Norland, (ii) $1.8 million in remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event, (iii) $1.4 million of executive transition and payroll related costs that we do not anticipate repeating in the future. For the three months ended December 31, 2021, other costs represent (i) $5.1 million of remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event (ii) $0.5 million of certain professional fees & payroll related costs we do not expect to incur in the future. For the twelve months ended December 31, 2022, (i) $7.2 million related to certain professional fees incurred related to integration, (ii) $6.8 million in remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event, (iii) $5.3 million associated with the transition of CEOs as well as other one-time executive payroll related costs that we do not anticipate repeating in the future. For the twelve months ended December 31, 2021, other costs represent (i) $5.6 million of one-time logistics charges incurred primarily due to supplier constraints and port issues (ii) $6.2 million of remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event (iii) $2.0 million of costs associated with our IPO and Follow-on Offering (iv) $1.7 million of professional fees and payroll related costs we do not expect to incur in the future.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<sup>(e)</sup> Represents the estimated tax impact of all Adjusted Net Income add-backs, excluding those which represent permanent differences between book versus tax.

## Exhibit 99.2

![](a2022_q4earningspresenta001.jpg)

1 Array Technologies 4Q 2022 Earnings Call March 21, 2023

------

![](a2022_q4earningspresenta002.jpg)

2 Disclaimer Forward-Looking Statements and Other Information This presentation contains forward-looking statements, as the term is used within federal securities laws. All statements other than those of historical fact which appear in this presentation, including (without limitation) statements regarding our future results, financial positions, operations, business strategies, plans, objectives, expectations, intentions, and predictions, are forward-looking statements. Additional indicators that a statement is forward-looking may include the use of descriptors or qualifiers, such as: "anticipate," "believe," "could," "seek," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "will," "would" or similar expressions and the negatives of those terms. Important factors that could cause actual results to differ materially from our expectations include: (i) if demand for solar energy projects does not continue to grow or grows at a slower rate than we anticipate, our business will suffer; (ii) the viability and demand for solar energy are impacted by many factors outside of our control, which makes it difficult to predict our future prospects; (iii) a loss of one or more of our significant customers, their inability to perform under their contracts, or their default in payment, could harm our business and negatively impact revenue, results of operations and cash flow; (iv) a drop in the price of electricity derived from the utility grid or from alternative energy sources may harm our business, financial condition, results of operations and prospects; (v) defects or performance problems in our products could result in loss of customers, reputational damage and decreased revenue, and we may face warranty, indemnity and product liability claims arising from defective products; (vi) an increase in interest rates, or a reduction in the availability of tax equity or project debt capital in the global financial markets could make it difficult for customers to finance the cost of a solar energy system and could reduce the demand for our products; (vii) existing electric utility industry policies and regulations, and any subsequent changes, may present technical, regulatory and economic barriers to the purchase and use of solar energy systems, which may significantly reduce demand for our products or harm our ability to compete; (viii) the interruption of the flow of materials from international vendors could disrupt our supply chain, including as a result of the imposition of additional duties, tariffs and other charges on imports and exports; (ix) changes in the U.S. trade environment, including the imposition of import tariffs, could adversely affect the amount or timing of our revenues, results of operations or cash flows; (x) the reduction, elimination or expiration of government incentives for, or regulations mandating the use of, renewable energy and solar energy specifically could reduce demand for solar energy systems and harm our business; (xi) if we fail to, or incur significant costs in order to, obtain, maintain, protect, defend or enforce, our intellectual property and other proprietary rights, our business and results of operations could be materially harmed; (xii) we may need to defend ourselves against third-party claims that we are infringing, misappropriating or otherwise violating others' intellectual property rights, which could divert management's attention, cause us to incur significant costs and prevent us from selling or using the technology to which such rights relate; (xiii) significant changes in the cost of raw materials could adversely affect our financial performance; (xiv) we are dependent on transportation and logistics providers to deliver our products in a cost efficient manner, and disruptions to transportation and logistics, including increases in shipping costs, could adversely impact our financial condition and results of operations; (xv) the requirements of being a public company may strain our resources, divert management's attention and affect our ability to attract and retain qualified board members and officers; (xv) we face risks related to actual or threatened health epidemics, such as the COVID-19 pandemic, and other outbreaks, which could significantly disrupt our manufacturing and operations; (xvii) provisions in our certificate of incorporation and our bylaws may delay or prevent a change of control; (xviii) our integration of STI Norland; (xix) the ongoing conflict in Ukraine, (xx) uncertain credit and global financial markets, including rising inflation and interest rates and recent bank failures; (xxi) the implementation of the IRA may not deliver as much growth as we are anticipating; and (xxii) we may be unable to remediate our material weaknesses on a timely basis or at all These forward-looking statements are only predictions. They relate to future events, performance, and variables, and involve risks and uncertainties both known and unknown. It is possible that levels of activity, performance or achievements will materially differ from what is implied by the forward-looking statements contained within this presentation and associated materials and explication. Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely on these forward- looking statements as guarantees of future events, or implications of certainty. The forward-looking statements in this presentation represent our expectations as of the date the presentation was created. We anticipate that subsequent events and developments will cause our expectations to change. We undertake no obligation to update any forward-looking statement to reflect events or developments after the date on which the statement is made or to reflect the occurrence of unanticipated events except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date after the date of this presentation. Non-GAAP Financial Information This presentation includes certain financial measures that are not presented in accordance with U.S. generally accepted accounting principles ("GAAP"), including Adjusted EBITDA, Adjusted Net Income and Adjusted Net Income per share. We define Adjusted EBITDA as net income (loss) to common shareholders plus (i) interest expense, (ii) other (income) expense, (iii) income tax expense (benefit), (iv) depreciation expense, (v) amortization of intangibles, (vi) equity-based compensation, (vii) remeasurement of the fair value of contingent consideration, (viii) ERP implementation costs, (ix) certain legal expense and settlements, and (x) other costs. We define Adjusted Net Income as net income (loss) to common shareholders plus (i) amortization of intangibles, (ii) amortization of debt discount and issuance costs (iii) equity-based compensation, (iv) remeasurement of the fair value of contingent consideration, (v) ERP implementation costs, (vi) certain legal expense and settlements, (vii) other costs, and (viii) income tax (expense) benefit of adjustments. A detailed reconciliation between GAAP results and results excluding special items ("non-GAAP") is included within this presentation. We define Adjusted Net Income per share as Adjusted Net Income divided by the diluted weighted average number of shares outstanding for the applicable period. We present non-GAAP measures when we believe that the additional information is useful and meaningful to investors. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similar measures presented by other companies. The presentation of non-GAAP financial measures is not intended to be a substitute for, and should not be considered in isolation from, the financial measures reported in accordance with GAAP. See the Appendix for the reconciliations of certain non-GAAP financial measures to the comparable GAAP measures. Market and Industry Data This presentation also contains information regarding our market and our industry that is derived from third-party research and publications. That information may rely upon a number of assumptions and limitations, and we have not independently verified its accuracy or completeness.

------

![](a2022_q4earningspresenta003.jpg)

3 Business Update Kevin Hostetler

------

![](a2022_q4earningspresenta004.jpg)

4 Executive Summary \| 4Q and FY Results 4Q 2022 Highlights 4Q 2022 Select Financials ► Total revenue growth of 83%, Organic revenue growth of 22% ► Gross Margin of 20.0%, up 1530 bps from Q4 2021 ► Adjusted EBITDA increased to $51.7 million, from $0.5 million in Q4 2021 ► Free Cash Flow of $85.7 million $0.5 $51.7 Adjusted EBITDA(1) Adjusted EBITDA % 2021 2022 $219.9 $402.1 Revenue 2021 2022 (1) See Appendix for reconciliation of non-GAAP measures to the closest GAAP measure 0.2% 12.9% Full Year 2022 Highlights ► Total revenue growth of 92%, Organic revenue growth of 49% ► Gross Margin of 13.9%, up 420 basis points from 2021 ► Adjusted EBITDA increased to $128.7 million, from $43.2 million in FY 2021 ► Free Cash Flow of $130.9 million Full Year 2022 Select Financials $43.2 $128.7 Adjusted EBITDA(1) Adjusted EBITDA % 2021 2022 $853.3 $1,637.5 Revenue 2021 2022 5.1% 7.9%

------

![](a2022_q4earningspresenta005.jpg)

5 Industry & Market Update U.S. Outlook • Short-term outlook remains healthy despite timing uncertainty caused by module availability and IRA domestic content • IRA Manufacturing credits will represent earnings upside in the near and long-term, but its too early to estimate how much • Multi-year health of the industry remains incredibly strong on the back of the Inflation Reduction Act • Market growth will create geographic diversity in project sites requiring flexible product offerings • Strategic relationships across the value-chain will become increasingly important Rest of World Outlook • Post election, the Brazilian solar market is poised for healthy growth in 2023 • Australia expected to rebound as EPC and interconnect issues of the past improve; in-country content will be an important differentiator • Demand in Western Europe expected to be slightly tempered until regulators introduce meaningful legislation • Continue to evaluate other areas of the world as solar continues to expand

------

![](a2022_q4earningspresenta006.jpg)

6 Business & Offering Update A Full Suite of Tracker Offerings…. …Coupled With an Expanding Software Offering DuraTrack ► Industry's only tracker capable of 32 linked rows ► Fewest number of components ► Zero scheduled maintenance OmniTrack ► Specifically designed for uneven and challenging terrain ► Allows up to 1° slope change in the torque tube ► Forecasted reduction of up to 98% in site grading work H250 ► Designed for sites with irregular boundaries ► Supports highly angled blocks or fragmented project areas ► Demonstrated success across Europe and South America SmarTrack Diffuse and Backtracking ► Determines optimal row position based on site specifics ► Improves over time to optimize site performance SmarTrack Weather Response ► Launching Q2 2023 ► Connection to weather service providers ► Automated hail and snow stow

------

![](a2022_q4earningspresenta007.jpg)

7 Financial Update Nipul Patel

------

![](a2022_q4earningspresenta008.jpg)

8 4Q 2022 Financial Results Three Months Ended December 31, ($ in millions, except EPS Data) 2022 2021 Y/Y Revenue $402.1 $219.9 +$182.2 Gross margin 20.0% 4.7% + 1530 bps Net income (loss) to Common Shareholders ($17.3) ($32.1) +$14.8 Diluted EPS ($0.11) ($0.24) +$0.13 Adjusted EBITDA(1) $51.7 $0.5 +$51.2 Adjusted net income(1) $15.0 ($7.8) +$22.8 Adjusted, Diluted EPS(1) $0.10 ($0.06) +$0.16 Free Cash Flow(2) $85.7 ($98.5) +$184.2 (1) See Appendix for reconciliation of non-GAAP measures to the closest GAAP measure (2) Free Cash Flow calculated as cash from (used in) operating activities less purchase of property, plant and equipment 4Q Snapshot Q/Q Comparison ► Revenue up 83% from addition of $133 million of STI Norland business; organic increase in revenue of 22% due to higher ASP ► Gross margin increased to 20.0% from 4.7%; exiting the year within our "high teens to low twenties" benchmark ► Adjusted EBITDA increased to $51.7 million, compared to $0.5 million for the prior-year period on improved gross margin ► Free cash flow of $85.7 million a $184.2 million improvement from prior year on better working capital efficiency and improved profitability

------

![](a2022_q4earningspresenta009.jpg)

9 2022 Financial Results Full Year Ended, December 31, ($ in millions, except EPS Data) 2022 2021 Y/Y Revenue $1,637.5 $853.3 +$784.2 Gross margin 13.9% 9.7% + 420 bps Net income (loss) to Common Shareholders ($43.6) ($66.1) +$22.5 Diluted EPS ($0.29) ($0.51) $0.22 Adjusted EBITDA(1) $128.7 $43.2 +$85.5 Adjusted net income(1) $57.3 $8.7 +$48.6 Adjusted, Diluted EPS(1) $0.38 $0.07 +$0.31 Free Cash Flow(2) $130.9 ($266.5) +$397.4 (1) See Appendix for reconciliation of non-GAAP measures to the closest GAAP measure (2) Free Cash Flow calculated as cash from (used in) operating activities less purchase of property, plant and equipment Full Year Snapshot Y/Y Comparison ► Revenue up 92% from addition of $370 million of STI Norland business; organic increase of 49% due to both an increase in MW shipped and higher ASPs ► Gross margin increased to 13.9% from 9.7% driven larger proportion of projects with improved pass-through pricing of commodities ► Adjusted EBITDA increased to $128.7 million, compared to $43.2 million for the prior-year period on higher revenue and improved gross margin ► Free cash flow of $130.9 million a $397.4 million improvement from prior year on better working capital efficiency and improved profitability

------

![](a2022_q4earningspresenta010.jpg)

10 FY2023 Guidance (1) A reconciliation of projected adjusted EBITDA and adjusted net income per share, which are forward-looking measures that are not prepared in accordance with GAAP, to the most directly comparable GAAP financial measures, is not provided because we are unable to provide such reconciliation without unreasonable effort. The inability to provide a quantitative reconciliation is due to the uncertainty and inherent difficulty predicting the occurrence, the financial impact and the periods in which the components of the applicable GAAP measures and non-GAAP adjustments may be recognized. The GAAP measures may include the impact of such items as non-cash share-based compensation, revaluation of the fair-value of our contingent consideration, amortization of intangible assets and the tax effect of such items, in addition to other items we have historically excluded from adjusted EBITDA and adjusted net income per share. We expect to continue to exclude these items in future disclosures of these non-GAAP measures and may also exclude other similar items that may arise in the future (collectively, "non-GAAP adjustments"). The decisions and events that typically lead to the recognition of non-GAAP adjustments are inherently unpredictable as to if or when they may occur. As such, for our 2023 outlook, we have not included estimates for these items and are unable to address the probable significance of the unavailable information, which could be material to future results. Revenue $1.80 billion to $1.95 billion Adjusted EBITDA(1) $240 million to $265 million Adjusted net income per common share(1) $0.75 to $0.85 Full Year Ending December 31, 2023 ► Adjusted SG&A between $30 million - $33 million per quarter ► Interest between $10 - $11 million per quarter ► Preferred dividends between $13 - $14 million per quarter ► Effective Tax Rate for Adjusted EPS: 24% - 26% ► Free Cash Flow of >$100 million Planning Assumptions Segment Specifics Legacy Array STI Norland Revenue $1.375 billion to $1.475 billion $425 million to $475 million Gross Margin Low Twenties Low Twenties

------

![](a2022_q4earningspresenta011.jpg)

11 Appendix

------

![](a2022_q4earningspresenta012.jpg)

12 Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Net income (loss) $(5,251) $(21,901) $4,432 $(50,403) Preferred dividends and accretion 12,009 10,236 48,054 15,715 Net loss to common shareholders $(17,260) $(32,137) $(43,622) $(66,118) Other income (expense), net (2,816) 408 (2,789) 905 Legal settlement(a) — — (42,750) — Foreign currency (gain) loss 813 — (1,155) — Preferred dividends and accretion 12,009 10,236 48,054 15,715 Interest expense 9,804 6,706 33,513 35,475 Income tax (benefit) expense 13,799 (5,225) (9,384) (10,718) Depreciation expense 704 614 2,571 2,439 Amortization of intangibles 24,667 5,877 98,188 23,507 Equity-based compensation 3,091 2,052 14,768 16,323 Contingent consideration 1,474 1,625 (4,507) 2,696 Legal expense(b) 984 1,549 5,990 2,574 M&A(c) (206) 3,125 10,564 4,867 Other costs (d) 4,635 5,623 19,291 15,553 Adjusted EBITDA $51,698 $453 $128,732 $43,218 Adjusted EBTIDA Reconciliation ($ in thousands) (a) Settlement in our favor resulting from the action against a competitor in connection with violation of a non-competition agreement and misappropriation of trade secrets. (b) Represents certain legal fees and other related costs associated with (i) action against a competitor in connection with violation of a non-competition agreement and misappropriation of trade secrets for which a judgement has been entered in our favor, (ii) actions filed against the company and certain officers and directors alleging violations of the Securities Exchange Acts of 1934 and 1933, and (iii) other litigation/settlements. We consider these costs not representative of legal costs that we will incur from time to time in the ordinary course of our business. (c) Represents fees related to the acquisition of STI Norland. (d) For the three months ended December 31, 2022, other costs represent (i) $1.4 million related to certain professional fees incurred related to the integration of STI Norland, (ii) $1.8 million in remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event, (iii) $1.4 million of executive transition and payroll related costs that we do not anticipate repeating in the future. For the three months ended December 31, 2021, other costs represent (i) $5.1 million of remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event (ii) $0.5 million of certain professional fees & payroll related costs we do not expect to incur in the future. For the twelve months ended December 31, 2022, (i) $7.2 million related to certain professional fees incurred related to integration, (ii) $6.8 million in remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event, (iii) $5.3 million associated with the transition of CEOs as well as other one-time executive payroll related costs that we do not anticipate repeating in the future. For the twelve months ended December 31, 2021, other costs represent (i) $5.6 million of one-time logistics charges incurred primarily due to supplier constraints and port issues (ii) $6.2 million of remediation and damages incurred because of a shutdown of a key supplier due to a severe weather (iii) $2.0 million of costs associated with our IPO and Follow-on Offering (iv) $1.7 million of professional fees and payroll related costs we do not expect to incur in the future.

------

![](a2022_q4earningspresenta013.jpg)

13 Adjusted Net Income Reconciliation ($ in thousands) (a) Represents certain legal fees and other related costs associated with (i) action against a competitor in connection with violation of a non-competition agreement and misappropriation of trade secrets for which a judgement has been entered in our favor, (ii) actions filed against the company and certain officers and directors alleging violations of the Securities Exchange Acts of 1934 and 1933, and (iii) other litigation/settlements. We consider these costs not representative of legal costs that we will incur from time to time in the ordinary course of our business. (b) Represents fees related to the acquisition of STI Norland. (c) Settlement in our favor resulting from the action against a competitor in connection with violation of a non-competition agreement and misappropriation of trade secrets. (d) For the three months ended December 31, 2022, other costs represent (i) $1.4 million related to certain professional fees incurred related to the integration of STI Norland, (ii) $1.8 million in remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event, (iii) $1.4 million of executive transition and payroll related costs that we do not anticipate repeating in the future. For the three months ended December 31, 2021, other costs represent (i) $5.1 million of remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event (ii) $0.5 million of certain professional fees & payroll related costs we do not expect to incur in the future. For the twelve months ended December 31, 2022, (i) $7.2 million related to certain professional fees incurred related to integration, (ii) $6.8 million in remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event, (iii) $5.3 million associated with the transition of CEOs as well as other one-time executive payroll related costs that we do not anticipate repeating in the future. For the twelve months ended December 31, 2021, other costs represent (i) $5.6 million of one-time logistics charges incurred primarily due to supplier constraints and port issues (ii) $6.2 million of remediation and damages incurred because of a shutdown of a key supplier due to a severe weather event (iii) $2.0 million of costs associated with our IPO and Follow-on Offering (iv) $1.7 million of professional fees and payroll related costs we do not expect to incur in the future. (e) Represents the estimated tax impact of all Adjusted Net Income add-backs, excluding those which represent permanent differences between book versus tax. Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Net income (loss) $(5,251) $(21,901) $4,432 $(50,403) Preferred dividends and accretion 12,009 10,236 48,054 15,715 Net loss to common shareholders $(17,260) $(32,137) $(43,622) $(66,118) Amortization of intangibles 24,667 5,877 98,188 23,507 Amortization of debt discount and issuance costs 1,854 1,039 6,858 15,036 Preferred accretion 6,009 4,805 23,249 7,489 Equity based compensation 3,091 2,052 14,768 16,323 Contingent consideration 1,474 1,625 (4,507) 2,696 Legal expense(a) 984 1,549 5,990 2,574 M&A (b) (206) 4,740 10,564 6,482 Legal settlement(c) — — (42,750) — Other costs(d) 4,635 5,623 19,291 15,553 Income tax expense of adjustments(e) (10,205) (3,669) (30,773) (15,473) Non-recurring income tax adjustments related to the IRS settlement and CARES Act — 662 — 662 Adjusted Net Income (Loss) $15,043 $(7,834) $57,256 $8,731

------

![](a2022_q4earningspresenta014.jpg)

14 Adjusted EPS Reconciliation Three Months Ended December 31, Year Ended December 31, 2022 2021 2022 2021 Loss per common share Basic $(0.11) $(0.25) $(0.29) $(0.51) Diluted $(0.11) $(0.25) $(0.29) $(0.51) Weighted average common shares outstanding Basic 150,463 130,146 149,819 129,984 Diluted 150,463 130,146 149,819 129,984 Adjusted income (loss) per common share Basic $0.10 $(0.06) $0.38 $0.07 Diluted $0.10 $(0.06) $0.38 $0.07 Weighted average common shares outstanding Basic 150,463 134,991 149,819 129,984 Diluted 151,571 134,991 150,436 130,146

------